Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.

1. Immuno Oncology (I-O)
Market
Market $38.89 Billion By 2025 | CAGR: 21.8%

2. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 2 -
“According to Polaris Market Research report, Immuno Oncology market is witnessing major innovations
& transformations and is anticipated to reach $ 38.89 Billion by 2025, registering a CAGR of 21.8% during
the forecast period 2020 to 2025.
The global Immuno Oncology market report sheds light on the key dynamics of the global market, analyzing
the data on a historical basis and forecasted data till the year 2028 The market analysis covered in the report
includes data in terms of value $ 38.89 Billion. The market overview section of the report covers the global
industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics
section of this report includes major drivers, restraints, trends, and opportunities emerging in the market.
Immuno Oncology Market Report Scope:
The global Immuno Oncology market is segmented based on type, application and geographic region.. The
motive of the research report is to define market dynamics of different countries & segments in the recent
time and to forecast the values for the coming years. The report is specifically designed to incorporate
quantitative and qualitative aspects of the market within each country and region involved in the study.
The report caters the extensive information regarding the driving factors & hurdles that will define the future
outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for
stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent
players shaping the overall development of the market.

3. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 3 -
By Treatment Type By Novel Target Type By Tumor or Cancer Type By Region Type
• Monoclonal
Antibodies
• Therapeutic
Vaccines
• Checkpoint
Inhibitors
Cytokines
• Oncolytic virus
• STING agonist
• TLR agonist
• HDACi
• TIL
• VEGFi
• MEKi
• TIGIT
• Melanoma
• Non-small cell lung
cancer
• Renal cell
carcinoma
• Head, face & neck
cancer
• Bladder cancer
• Classical hodgkin’s
lymphoma
• Merkel cell
carcinoma
• North America (U.S.,
Canada)
• Europe (Germany, UK,
France, Italy Spain)
• Asia Pacific (India,
Japan, China, South
Korea)
• Latin America (Brazil,
Mexico, Colombia)
MEA (Saudi Arabia, South
Africa, Israel, UAE)
COVID-19 Impact Analysis for Immuno Oncology Market
COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its long-
term effects are expected to influence the target industry growth over the forecast period. Our ongoing
research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues
and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior
and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the
interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts,
considering the COVID-19 impact on the market.
Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic
impacting the the Immuno Oncology market in different regions and how leading players are forming
strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities :

4. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 4 -
Browse Detailed Research Report On Immuno Oncology Market Analysis:
https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market
Regional Outlook
Among regional markets, the region emerged as the promising regional market with its higher revenue share
contribution. The growth in this regional market is primarily attributed to the ongoing technological
advancements in the industry, increasing economic stability, huge government investments, and growing
awareness related to the benefits of the product/service.
Competitive Landscape
The report offers a complete industry analysis while featuring the competitive landscape that includes
company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a
detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional
landscape, major investments, and details of historical, present, and projected revenues. According to Polaris
Market Research, the key players with a noteworthy dominance in the Immuno Oncology market include
Bristol Myers Squibb, Merck, AstraZeneca, Roche Holding AG, Pfizer Inc., and Incyte Corporation
Request for sample: https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-
market/request-for-sample
Table of Contents
1. Chapter 1. Introduction
1.1. Report Description
2. Chapter 2. Executive Summary
3. Chapter 3. Research Methodology Overview
3.1. Research Process
3.1.1. Information procurement
3.1.2. Purchased database:
3.1.3. Polaris Market Research’s internal database
3.2. Research Methodology
3.3. Research Scope & Assumptions
3.4. List of Data Sources
4. Chapter 4. Market Insights
4.1. Immuno Oncology: Industry Snapshot
4.2. Market Dynamics
4.3. Immuno Oncology market Forces
4.3.1. Drivers
4.3.1.1. Increasing introduction of unconventional and advanced treatment
techniques
4.3.1.2. Rapidly growing population of various cancer infected patients

5. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 5 -
4.3.2. Restraints
4.3.2.1. Limited access and awareness about immunotherapy
4.3.3. Opportunity analysis: Immunology-oncology market
4.3.3.1. Increasing demand for improved cancer care by patients
4.4. Porter’s Five Forces Analysis
4.5. PEST Analysis: Immuno-Oncology Market
4.6. Five forces shaping the immuno-oncology market
5. Chapter 5. Immuno Oncology Market Estimates and Forecast, by Treatment Type
5.1. Market size by treatment type
5.2. Monoclonal Antibodies
5.2.1. Global immuno oncology monoclonal antibodies treatment market estimates &
forecasts by region, 2015-2025
5.3. Therapeutic Vaccines
5.3.1. Global immuno oncology therapeutic vaccines treatment market estimates &
forecasts by region, 2015-2025
5.4. Checkpoint Inhibitors
5.4.1. Global immuno oncology checkpoint inhibitors treatment market estimates &
forecasts by region, 2015-2025
5.5. Cytokines
5.5.1. Global immuno oncology cytokines treatment market estimates & forecasts by
region, 2015-2025
6. Chapter 6. Immuno Oncology Market Estimates and Forecast, by Novel Target Type
6.1. Market size by novel target type
6.2. IDO1i
6.2.1. Global immuno oncology market estimates & forecasts for IDO1i target by
region, 2015-2025
6.3. LAG-3 CPI
6.3.1. Global immuno oncology market estimates & forecasts for LAG-3 CPI target by
region, 2015-2025
6.4. Oncolytic virus
6.4.1. Global immuno oncology market estimates & forecasts for Oncolytic virus target
by region, 2015-2025
6.5. STING agonist
6.5.1. Global immuno oncology market estimates & forecasts for STING agonist target
by region, 2015-2025
6.6. TLR agonist
6.6.1. Global immuno oncology market estimates & forecasts for TLR agonist target by
region, 2015-2025
6.7. HDACi
6.7.1. Global immuno oncology market estimates & forecasts for HDACi target by
region, 2015-2025
6.8. TIL
6.8.1. Global immuno oncology market estimates & forecasts for TIL target by region,
2015-2025
6.9. VEGFi
6.9.1. Global immuno oncology market estimates & forecasts for VEGFi target by
region, 2015-2025
6.10. MEKi
6.10.1.Global immuno oncology market estimates & forecasts for MEKi target by
region, 2015-2025

6. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 6 -
6.11. TIGIT
6.11.1.Global immuno oncology market estimates & forecasts for TIGIT target by
region, 2015-2025
6.12. CPI
6.12.1.Global immuno oncology market estimates & forecasts for CPI target by region,
2015-2025
6.13. GITR agonist
6.13.1.Global immuno oncology market estimates & forecasts for GITR agonist target
by region, 2015-2025
6.14. TGF-b trap
6.14.1.Global immuno oncology market estimates & forecasts for TGF-b trap target by
region, 2015-2025
6.15. A2AR antagonist/CD73i
6.15.1.Global immuno oncology market estimates & forecasts for A2AR
antagonist/CD73i target by region, 2015-2025
7. Chapter 7. Immuno Oncology Market Estimates and Forecast, by Tumor or Cancer Type
7.1. Market size by tumor or cancer type
7.2. Melanoma
7.2.1. Global immuno oncology market estimates & forecasts for melanoma cancer by
region, 2015-2025
7.3. Non-small cell lung cancer
7.3.1. Global immuno oncology market estimates & forecasts for non-small cell lung
cancer by region, 2015-2025
7.4. Renal cell carcinoma
7.4.1. Global immuno oncology market estimates & forecasts for renal cell carcinoma
cancer by region, 2015-2025
7.5. Head, face & neck cancer
7.5.1. Global immuno oncology market estimates & forecasts for head, face & neck
cancer by region, 2015-2025
7.6. Bladder cancer
7.6.1. Global immuno oncology market estimates & forecasts for bladder cancer by
region, 2015-2025
7.7. Classical hodgkin’s lymphoma
7.7.1. Global immuno oncology market estimates & forecasts for classical hodgkin’s
lymphoma cancer by region, 2015-2025
7.8. Merkel cell carcinoma
7.8.1. Global immuno oncology market estimates & forecasts for merkel cell carcinoma
cancer by region, 2015-2025
7.9. Other cancer types
7.9.1. Global immuno oncology market estimates & forecasts for other cancer types by
region, 2015-2025
8. Chapter 8. Immuno Oncology Market Estimates and Forecast, by Region
8.1. Market size by region
8.2. North America
8.2.1. North America immuno oncology market estimates & forecasts by treatment
type, 2015-2025
8.2.2. North America immuno oncology market estimates & forecasts by novel target
type, 2015-2025
8.2.3. North America immuno oncology market estimates & forecasts by tumor type,
2015-2025

7. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 7 -
8.2.4. U.S.
8.2.4.1. U.S. immuno oncology market estimates & forecasts by treatment type,
2015-2025
8.2.4.2. U.S. immuno oncology market estimates & forecasts by novel target type,
2015-2025
8.2.4.3. U.S. immuno oncology market estimates & forecasts by tumor type, 2015-
2025
8.2.5. Canada
8.2.5.1. Canada immuno oncology market estimates & forecasts by treatment
type, 2015-2025
8.2.5.2. Canada immuno oncology market estimates & forecasts by novel target
type, 2015-2025
8.2.5.3. Canada immuno oncology market estimates & forecasts by tumor type,
2015-2025
8.2.6. Mexico
8.2.6.1. Mexico immuno oncology market estimates & forecasts by treatment
type, 2015-2025
8.2.6.2. Mexico immuno oncology market estimates & forecasts by novel target
type, 2015-2025
8.2.6.3. Mexico immuno oncology market estimates & forecasts by tumor type,
2015-2025
8.3. Europe
8.3.1. Europe immuno oncology market estimates & forecasts by treatment type, 2015-
2025
8.3.2. Europe immuno oncology market estimates & forecasts by novel target type,
2015-2025
8.3.3. Europe immuno oncology market estimates & forecasts by tumor type, 2015-
2025
8.3.4. Germany
8.3.4.1. Germany immuno oncology market estimates & forecasts by treatment
type, 2015-2025
8.3.4.2. Germany immuno oncology market estimates & forecasts by novel target
type, 2015-2025
8.3.4.3. Germany immuno oncology market estimates & forecasts by tumor type,
2015-2025
8.3.5. UK
8.3.5.1. UK immuno oncology market estimates & forecasts by treatment type,
2015-2025
8.3.5.2. UK immuno oncology market estimates & forecasts by novel target type,
2015-2025
8.3.5.3. UK immuno oncology market estimates & forecasts by tumor type, 2015-
2025
8.4. Asia Pacific
8.4.1. Asia Pacific immuno oncology market estimates & forecasts by treatment type,
2015-2025
8.4.2. Asia Pacific immuno oncology market estimates & forecasts by novel target type,
2015-2025
8.4.3. Asia Pacific immuno oncology market estimates & forecasts by tumor type,
2015-2025
8.4.4. China

8. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 8 -
8.4.4.1. China immuno oncology market estimates & forecasts by treatment type,
2015-2025
8.4.4.2. China immuno oncology market estimates & forecasts by novel target
type, 2015-2025
8.4.4.3. China immuno oncology market estimates & forecasts by tumor type,
2015-2025
8.4.5. India
8.4.5.1. India immuno oncology market estimates & forecasts by treatment type,
2015-2025
8.4.5.2. India immuno oncology market estimates & forecasts by novel target type,
2015-2025
8.4.5.3. India immuno oncology market estimates & forecasts by tumor type,
2015-2025
8.4.6. Japan
8.4.6.1. Japan immuno oncology market estimates & forecasts by treatment type,
2015-2025
8.4.6.2. Japan immuno oncology market estimates & forecasts by novel target
type, 2015-2025
8.4.6.3. Japan immuno oncology market estimates & forecasts by tumor type,
2015-2025
8.5. Central & South America (CSA)
8.5.1. CSA immuno oncology market estimates & forecasts by treatment type, 2015-
2025
8.5.2. CSA immuno oncology market estimates & forecasts by novel target type, 2015-
2025
8.5.3. CSA immuno oncology market estimates & forecasts by tumor type, 2015-2025
8.5.4. Brazil
8.5.4.1. Brazil immuno oncology market estimates & forecasts by treatment type,
2015-2025
8.5.4.2. Brazil immuno oncology market estimates & forecasts by novel target
type, 2015-2025
8.5.4.3. Brazil immuno oncology market estimates & forecasts by tumor type,
2015-2025
8.6. Middle East & Africa (MEA)
8.6.1. MEA immuno oncology market estimates & forecasts by treatment type, 2015-
2025
8.6.2. MEA immuno oncology market estimates & forecasts by novel target type, 2015-
2025
8.6.3. MEA immuno oncology market estimates & forecasts by tumor type, 2015-2025
9. Chapter 9. Company Profiles
9.1. Bristol Myers Squibb
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Developments
9.2. Merck & Co.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Developments

9. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 9 -
9.3. AstraZeneca
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Developments
9.4. Roche Holding AG
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Developments
9.5. Pfizer Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Developments
9.6. Incyte Corporation
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Developments
9.7. Seattle Genetics
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Developments
Access Press Release on Immuno Oncology Market: https://www.polarismarketresearch.com/press-
releases/immuno-oncology-i-o-market
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in
providing exceptional market intelligence and in-depth business research services for our clientele spread
across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the
industries of healthcare, technology, semi-conductors, and chemicals among various other industries present
around the world. We strive to provide our customers with updated information on innovative technologies,
high growth markets, emerging business environments, and the latest business-centric applications, thereby
helping them always to make informed decisions and leverage new opportunities. Adept with a highly
competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants,
we at Polaris endeavor to deliver value-added business solutions to our customers.
E mail Id: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

10. Animal Feed Market Size Worth $ 568.5 Billion By 2028
- 10 -
Official Blog: http://polarismarketresearch.blogspot.com